Swiss drugmaker Novartis to invest $23bn in US manufacturing and R&D
[ad_1] Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Swiss pharma group Novartis
Drugmaker merger turns the page on a dark chapter of US history
[ad_1] Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. America loves second chances.
